This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

ALAN R. HINMAN, MD
Center for Prevention Services Centers for Disease Control Atlanta, GA 30333

Am J Dis Child. 1988;142(12):1275-1276.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Sir.—My 1986 article¹ summarized the experience of the three manufacturers of diphtheria and tetanus toxoids and pertussis (DTP) vaccine from 1978 through 1985. I recently obtained summary information from the manufacturers about their experiences in 1986 and 1987. The results are shown in the Table. The number of doses of DTP vaccine distributed in the United States stayed relatively constant during that time. The number of suits filed reached a peak in 1986, with 255 filed, and declined to 178 in 1987 (Figure). As in previous years, somewhat more than half of the suits specified an amount sought. In 1986, the specified amount sought totaled nearly $2.2 billion; this declined to $1.2 billion in 1987. The average amount sought decreased progressively from 1984 through 1987.

. . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?